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Abstract. The effects of lithium chloride, given IP in 
high (2 .5 -15  mEq/kg) and low (1.25 mEq/kg) doses 
twice daily, upon 3H-norepinephrine uptake and re- 
tention were examined with slices from four regions of 
the rat brain, namely brain stern, hypothalamus, pa- 
rietal cortex, and caudate nucleus. Control uptake was 
significantly higher in slices from the caudate nucleus 
and lower i~ brain stem slices than in slices from 
hypothalamus or parietal cortex. With the higher doses, 
uptake increased significantly in al! regions after 2 days 
of treatment and returned to normal by 7 days. With 
the lowest dose, uptake was increased after 7 days but 
normal at 14 days. Only in caudate slices was there a 
second elevation of 3H-norepinephrine uptake after 
21 days of treatment, which returned to normaI by 
42 days. No other effects were observed during 70 days 
of treatment with lithium. The correlation between 
changes in 3H-norepinephrine uptake and ptasma 
lithium levels was studied. 
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The 'biogenic amine hypothesis' of  major affective 
disorders predicts that the neuropharmacologic 
changes in mania should lead to an excess of norepi- 
nephrine (NE) (and other amines) at post-synaptic 
receptor sites (Schildkraut, ~ 973; Shopsin et al., 1974). 
Therefore, a specific antimanic drug, such as lithium, 
shou!d reduce the post-synaptic availability or effec- 
tiveness of NE. Several experimental attempts to verify 
this prediction in animals have been reported. Acute 
and subacute studies (10 days or less of lithium 
treatment) have demonstrated a slight decrease in NE 
coment (Leonard, i975) and an increase of NE turn- 
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over in the rat brain (Corrodi et al., 1967; Sterne et al., 
t969; Schildkraut et at., t969; Greenspan et al., 1970; 
Poitou and Bohuon, 1975), a decrease in stimulated 
neuronal release i~ rat brain slices (Katz et ai., 1968), 
and an increase in labeled NE uptake by rat brain 
synaptosomes (Colburn et al.: 1967; Kuriyama and 
Speken, 1970). All of these findings are consistent with 
a lithium-induced decrease in the post-synaptic avail- 
ability of NE. 
There have been no studies of the effects of long- 
term lithium administration upon the uptake of NE by 
various regions of the brain. Two weeks or more of 
!ithium treatment did not affect NE turnover (Corrodi 
et al ,  1969; Ho et al., 1970; Bliss and Ailion, 1970; 
Poitou and Bohuon, 1975) in various rat brain prepara- 
tions. Nevertheless, the clinical antimanic effect of 
lithium persists in some patients for months to years 
(Klerman, !978). There are significant procedural 
differences among these previous experiments, such as 
the system studied (i.e., uptake versus turnover, slices 
versus synaptosomes), dose level and dosage regimen, 
use of metabolic inhibitors, and the method and route 
of administration of both lithium and exogenous NE. 
Thus, it is difficult to compare these experiments. A!so, 
there is only limited intbrmation on regional brain 
differences (Ho et al., 1970). The purpose of the present 
study was to compare the effects of short- and long- 
term. lithium administration upon 3H-NE uptake by 
siices from various regions of the rat brain. Knapp and 
Mandell (1975) have demonstrated that the effect of 
tithium on the biosnthesis of 5-hydroxytryptamine (5- 
HT) is temporally biphasic. If the effect of lithium upon 
catecholamine-containing neurons in the brain is also 
biphasic, a parametric study with a consistent pro- 
cedure would be necessary to demonstrate this effec:. 
Materials  and Mefl~eds 
.5M~jeeta. Male Sprague-Dawley rats: weighing 200-250 g at r 
begim~ing of" the experimental periods, ,a.ere obtained flom Spartan 
0033-3158i80/0067/008 !/5501.00 
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Table 1. Doses of lithium chloride, dosage regimens, and time of 
sacrifice for rats in high- and low-dose groups 
Groups Dose Dosage regimen Time of sacrifice 
(mEq/kg) (after the last dose) 
High dose 15 1 dose 2 or 16 h 
5 twice daily for 2 days 16 h 
2.5 twice daily for 7 days 16 h 
Low dose 1.25 1 dose 2or  16h 
1.25 twice daily for 2, 7, 14 16 h 
21, 42, or 70 days 
Farms in Lansing, Michigan. All animals were maintained in a small 
mammal laboratory colony with regulated light-dark cycle, tempera- 
ture, and humidity. They received rat chow and water ad libitum. 
Those animals treated with the high-dose regimen tended to show 
diarrhea, and at the highest dose a 25 ~ mortality rate was observed. 
The low-dose subjects, however, not only maintained their body 
weights but continued to grow, weighing up to 400 g by week 10. In 
these animals, diarrhea was not present after day 7 of treatment. 
Drugs. Lithium chloride dissolved in sterile water was administered 
IP to experimental subjects twice daily at 8 a.m. and 8 p.m. ; control 
rats received 1P saline injctions instead of lithium chloride. Frazer et 
al. (1973) have shown that brain levels of lithium are stable for 16 h 
when given for 10 days on a twice-daily basis. Indeed, there was only 
a one-and-a-half-fold difference over 16 h after a single injection. 
3H-NE was obtaind from New England Nuclear (> 99 % purity). 
Dosage Regimens. For the lithium-treated subjects, two dosage 
regimens were used, a high dose and a low dose (Table I). The high- 
dose subjects received the maximally tolerated dose for each specified 
treatment duration (twice the specified dose produced mortality rates 
above 50 %). These animals received 15 mEq/kg once only, 5 mEq/kg 
twice daily for 2 days, or 2.5 mEq/kg twice daily for 7 days. Some of 
the single-dose (15 mEq/kg) subjects were killed 2 h post-injection; 
all others were killed 16 h after the last injection. At 14 days and 
thereafter, the maximally tolerated dose was 1.25 mEq/kg (equiva- 
lent to the low dose). Therefore, the high-dose regimen ended at 
7 days. 
In the low-dose regimen, all rats received 1.25 mEq/kg once only 
or twice daily for 2, 7, 14, 21, 42, or 70 days. Some of the single-dose 
subjects were killed 2 h post-injection; all others were killed 16 h after 
the last injection. 
Measurement of 3H-NE Uptake. 3H-NE uptake was determined as 
discussed previously (Steinberg and Smith, 1970). Animals were 
killed by decapitation. Brains were immediately removed and placed 
in ice-cold Krebs-Heinzleit buffer solution. Two 0.5-ram thick slices 
were cut, from each half of the brain, from four different brain 
regions:brain stem, hypothalamus, parietal cortex, and caudate 
nucleus. 
Brain slices were incubated for 10 min in the presence of 10-VM 
3H-NE. Preliminary studies showed that the uptake of 3H-NE is 
linear over a 20-min period. The slices were then washed twice with 
fresh buffer and incubated for 6 min further. The slices were then 
homogenized in ice-cold 5 % trichloroacetic acid, centrifuged, and the 
supernatant was collected. NE was extracted on alumina columns 
and eluted with 0.2 N acetic acid into scintillation vials. 
Samples were counted in a model 2003 Packard Tri Carb liquid 
scintillation spectrometer for a period of time sufficient to give a 
standard error of counting less than 2 %. Recovery of NE was 75 
• 3 %. All values represent the means of at least six determinations. 
Analysis of variance was used to determine the significance of 
differences (Myers, 1966). 
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Fig. 1. Uptake of 3H-norepinephrine by rat brain slices. Abscissa: C 
control. Arabic numbers represent number of days of treatment with 
lithium before sacrifice: 0.1 days, six animals killed 2 h after a single 
dose; and 0.7 days, six animals killed 16 h after a single dose. All 
other times represent six to ten animals killed 16 h after 2, 7, or 
14 days, respectively, of twice-daily injections. Ordinate: 3H- 
norepinephrine expressed as pmol/g of tissue. Each bar represents the 
mean value. Vertical lines represent SEM: a P<  0.05; b p < 0.005; 
I brainstem, H hypothalarnus, III parietal cortex, and IV caudate 
nucleus. In each quandrant, the upper graph represents observations 
made with the high-dose regimen; lower graph represents obser- 
vations made with the low-dose regimen. In each brain region the 
data at 0.1, 0.7, 2, and 7 days are from different animals for the high- 
and low-dose regimens; the control and 14-day data, however, are 
from the same animals. They are represented twice, under both 
regimens, for ease of comparison. See text for details 
Measurement or Plasma Lithium. Lithium levels were determined 
with a model 305B Perkins-Elmer atomic absorption spectrometer. 
Levels were determined at 2 and 16 h after a single dose of either 1.25 
or 15 mEq/kg, at 2 and 16 h after the last dose of either 1.25 or 
5 mEq/kg given twice daily for 2 days, and at 2 and 16 h after the last 
dose of 1.25 mEq/kg given twice daily for 14 days. 
Results 
C o n t r o l  slices f r o m  the  fou r  b r a i n  r eg ions  d i f f e red  in the  
a m o u n t  o f  3 H - N E  w h i c h  was  t a k e n  u p  (Fig.  1). T h e  
l a rges t  a m o u n t  was  t a k e n  up  by  c a u d a t e  slices, a n d  the  
smal l e s t  by  b r a i n  s t e m  slices. Slices f r o m  the  hy-  
p o t h a l a m u s  a n d  pa r i e t a l  co r t ex  t o o k  up  i n t e r m e d i a t e  
a m o u n t s .  
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Table 2. Uptake of 3H-norepinephrine by slices (pmol/g of tissue) 
from four regions of the rat brain after variot~s periods of treatment 
with lithium chloride ~ 
Contro[ 21 days 42 days 70 days 
Brainstem 61+ 4.7 71 +10.:5 51:~ 7.8 79+ 5,5 
Hypothalamus 94-+ 7.7 147 • 84+I7.4 110_+ 9,5 
Parie{alcortex !0!_+ 6.9 138 -+26A 88• /82_+10.1 
CaL~date~lucteus i49_+15,9 317b+51.2 153-+37.5 i82-+27.8 
Each value represents the mean of at least six determinations + 
SEM 
b p <  0.025 
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Tabie 3. Plasma lithium levels (mEq/l) ~ obtained at 2 and [6 h after 
~.he designated doses 
15mEq/kg 5mgq/kg 1.25mgq/kg 1.25mEq/kg 
? Dose Twicedaiiy 1 Dose Twice daily 
2 Days 
2 Days 14 Days 
2h  10.721.3 2.9_+1.3 0.97+0.10 0.42_+0.08 0.53+_0.09 
I6h 3.9• 1.0 2.0_+0.5 0.07_+0.04 0.08~0.04 0.14+0.05 
~ Mean of six determinations +_ SEM 
In slices from all four brain regions, the uptake Of 
3H-NE was increased significantly ( P <  0.05) after 
7 days of administration of the lowest dose of !ithium 
(1.25 mEq/kg). At no other time was the uptake after 
this dose significantly different from control in any 
brain region, and in al] four regions uptake returned to 
or below control values by day 14 of" treatment 
(Fig, 1). 
TSe increase in 3H-NE uptake occurred earlier with 
the administration of higher doses of lithium (Fig. 1). 
Although no brain areas showed a change from control 
values at 2 h after a single dose of  Iithium (15 mEq/kg), 
brain s::em slices showed a significant increase at 16 h 
after a single dose of" !5 mEq/kg ( P <  0.05). In slices 
from all regions, a significant increase was observed at 
2 days ( P <  0.005); these animals received 5 mEq/kg 
twice daily. At 7 days, with a twice-daily dose of 
2.5 mEq/kg, all subjects had retur :ed to control levels 
or below. In comparing the low to the high-dose groups 
at 2 days, the uptake by high-dose subjects was 
significantly greater than low-dose subjects (P < 0.005) 
in each brain region. At 7 days the reverse was true: 
uptake by brain sIices from low-dose animals was 
higher than for brain slices from high-dose subjects 
( P <  0_00~). 
Uptake of 3H-NE was also determined after 2J,, 42, 
and 70 days of treatment with 1.25 mEq/kg twice daily 
(Table 2). Only in caudate slices was there a significant 
increase in uptake ( P <  0.025), which occurred at 
21 days and returned to normal by 42 days. 
Plasma lithium levels were determined after various 
doses and durations of treatment (Table 3). At 2 h 
post-injection, the plasma concentrations which were 
achieved after a single dose of15 mEq/kg were approx- 
imately four-times greater than the concentrations 
achieved during the 2-day regimen with an intermediate 
dose of 5 mEq/kg twice daily, and approximately 20- 
times greater than the concentrations achieved after 
14 days or more at a dose of  1.25 mEq/kg twice daily. 
At 16 h post-injection, when plasma leve!s were stable, 
the concentrations achieved after a single dose of 
15 mEq/kg were oniy twice that achieved after the 2- 
day regimen with the intermediate dose of 5 mEq/kg, 
but still more than 20-times greater than the con- 
centration achieved with the chronic regimen. Plasma 
leveis 2 h after a single dose of 1.25 mEq/kg were twice 
as great as those after 2 days of treatment, which 
suggests that renal excretion of lithium takes approx- 
imately 2 days to stabiiize. 
Dise~ssio~ 
The results of the present study clarify the findings of  
previous investigations of  the effect of lithium on 
noradrenergic mechanisms: an increase in NE uptake 
within the first 2 weeks of administration, which could 
result in decreased post-synaptic availability of NE, 
followed by a return to control levels ('no effect') at 
later times. In ~his study, this pattern was consistent in 
all brain regions despite differences in control levels of 
uptake. 
The time of peak effects was dose dependent : the 
effects of the  higher doses occurred earlier and returned 
to controI levels earlier than the tow dose. This dose 
effect was not due purely to a delay in attainment of 
effective brain lithium levels. Frazer et al. (1973) 
demonstrated that brain lithium levels after 10 days of 
twice-daily injections are approximately the same as 
after only one injection. In this study, only in the brain 
stem was there an e2fect of a single lithium injection, 
which occurred after 16 h when the plasma, and 
presumably brain lithium levels, were lower than at 2 h 
post-injection. This observation indicates that even 
though a higher drug level had been obtained at 2 h, a 
delay occurred before the change in uptake was ob- 
served. Since it appears that the attainment of a high 
brain lithium level does not exp!ain the initial increase 
in NE uptake, some further change, still unidentified, 
presumably must occur. Never~heiess, different brain 
lithium levels do apparentIy determine when the effects 
occur. Estimations of brain lithium ievels in this study, 
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using comparisons o f  the plasma levels in this study to 
those o f  Frazer et al. (1973), and then extrapolating 
f rom the comparisons o f  brain to plasma levels in that  
study (Figs. 1 and 2 f rom Frazer et al., 1973) indicate 
that :  1) lithium ( i m E q / k g )  twice daily for 2 days 
produced brain levels considerably greater than those 
at 0.5 mEq/kg ;  2) 2.5 mEq/kg  twice daily for 7 days 
produced levels approximately equal to those at 
0.5 mEq/kg ;  and 3) 1.25 mEq/kg  twice daily for 2 days 
or more produced levels less than those at 0.5 mEq/kg.  
Therefore, higher tissue concentrat ions led to earlier 
effects. And,  a l though there are acute differences in 
lithium concentrat ions between the brain regions used 
in this study (Ebadi et al., 1974), at 2 days and thereafter 
concentrat ions in these brain regions become nearly 
equal (Bond et al., 1975). Therefore, differences in 
tissue lithium concentrat ions do not  explain absolute 
differences between brain regions. 
The present findings are partially consistent with 
the biogenic amine hypothesis of  affective disorders 
which suggests that  ant imanic drugs act in part  upon  
noradrenergic mechanisms. That  is, lithium increases 
tissue uptake o f  NE,  therefore, making it tess available 
to stimulate post-synaptic receptors. Two problems are 
evident, however. First, within 2 weeks, uptake re- 
turned to control levels. Al though lithium is clinically 
effective in reducing or preventing manic  behavior for 
extended periods of  time, the effect on N E  uptake is 
brief. Possible explanations are 1) that  over-availability 
of  N E  alone does not  account  for mania, 2) that  further 
mechanisms as well as uptake, or regional effects either 
in regions not  studied or in more localized brain areas, 
are also involved in the antimanic effect, or 3) that  the 
subjects are rats instead of  humans,  and presumably are 
not  manic. Second, lithium seems to be effective in at 
least some depressions (Mendels, 1976). To preserve 
consistency between the biogenic amine hypothesis and 
the demonstra ted effect of  lithium on depression, it will 
be necessary to explain how an increase in uptake 
would functionally lead to increased post-synaptic 
availability of  NE.  Maletzky and Blachly (1971) have 
suggested that  l i thium's major  effect may be one of  
stabilization of  neuronal  function;  such a mechanism 
may explain how lithium could have both  antimanic 
and antidepressant properties. 
This study shows that  the effect o f  lithium on 3H- 
NE uptake by brain slices is temporally biphasic, just  as 
it is on the metabolic conversion of  t ryptophan to 
serotonin (5-HT) (Knapp and Mandell, 1975). This 
biphasic response (initial per turbat ion followed by a 
compensatory  return to control lex, els) was demon-  
strated despite numerous  differences in the systems 
studied: 1) NE  uptake versus serotonin synthesis; 2) 
brain slices versus synaptosomes and biosynthetic 
enzymes;  3) four brain regions including striatum 
(caudate nucleus) versus str iatum only; 4) different 
doses o f  lithium used. Despite these differences, not  
only was a similar compensatory  response observed, 
but the time courses observed were similar, i.e., an 
initial response within the first week, followed by a 
return to control levels by 1 4 - 2 1  days. Interestingly, 
the second increase in uptake observed in this study in 
the caudate nucleus at 21 days suggests the need to look 
for, at later times in other systems, late effects which 
have been missed in previous time-limited studies. The 
findings of  analogous biphasic responses in different  
amine systems suggests that  such biphasic compen- 
satory mechanisms may be very c o m m o n  in a variety o f  
neuropharmacoiogical  systems. 
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